KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short term Debt (2018 - 2025)

Elanco Animal Health's Short term Debt history spans 8 years, with the latest figure at $74.0 million for Q4 2025.

  • For Q4 2025, Short term Debt rose 68.18% year-over-year to $74.0 million; the TTM value through Dec 2025 reached $74.0 million, up 68.18%, while the annual FY2025 figure was $74.0 million, 68.18% up from the prior year.
  • Short term Debt for Q4 2025 was $74.0 million at Elanco Animal Health, up from $62.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $605.0 million in Q1 2021 and bottomed at $38.0 million in Q4 2023.
  • The 5-year median for Short term Debt is $61.0 million (2021), against an average of $174.5 million.
  • The largest annual shift saw Short term Debt surged 2042.86% in 2021 before it plummeted 90.21% in 2023.
  • A 5-year view of Short term Debt shows it stood at $294.0 million in 2021, then skyrocketed by 31.97% to $388.0 million in 2022, then tumbled by 90.21% to $38.0 million in 2023, then rose by 15.79% to $44.0 million in 2024, then surged by 68.18% to $74.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Short term Debt are $74.0 million (Q4 2025), $62.0 million (Q3 2025), and $61.0 million (Q2 2025).